Tenaya Therapeutics’ Finance SVP Higa Tomohiro Accumulates 123,221 Shares in Bold Long‑Term Play Amid Market Decline
Tenaya Therapeutics insider buying: SVP Higa’s 2026 vesting & option grant shows long‑term confidence amid market dips, hinting at future upside.
4 minutes to read